X-Message-Number: 13508 Date: Sun, 09 Apr 2000 12:52:33 -0700 From: Olaf Henny <> Subject: Re: CryoNet #13499 - #13504 References: <> A few days ago Alteon Inc. announced the commencement of Phase II trials of their ALT-711 compound. An earlier announcement late summer/ early spring, 1999 advised, that Alteon was in negotiations with a very large Japanese pharmaceutical company, for the Asian distribution rights. It seems reasonable conjecture, that they have now obtained financing from that source, that this financing also covers the conclusion of Phase III and that Phase III clinical tests will be concluded by late 2001. Now here is my question to those, who have experience in such matters: What is a reasonable estimate of the time involved, after successful conclusion of Phase III, for bringing the drug through FDA approval and onto the market, assuming that the inherent financial hurdles are manageable, without causing any delay in addition to the approval process? Best, Olaf Rate This Message: http://www.cryonet.org/cgi-bin/rate.cgi?msg=13508